BioSpace News Archive

Recce Pharmaceuticals Ltd today announced the successful batch completion under Good Manufacturing Practices (GMP) for its lead candidate, RECCE® 327 (R327), with the patented manufacturing process now producing 5,000 GMP doses of R327 per week.

Psyence Biomedical Ltd today announced that details of its upcoming Phase IIb clinical trial of nature-derived psilocybin in patients diagnosed with Adjustment Disorder following an advanced cancer diagnosis in the Palliative Care context has been listed on the Australian New Zealand Clinical Trials Registry (“ANZCTR”), under registration number 12624000449538p.

Cardiovascular Centers of America proudly announces the launch of Florida’s the first complete cardiac ablation service line in an Ambulatory Surgery Center at Advanced Heart and Vascular Surgery Center.

Delve Bio in collaboration with the University of California, San Francisco (UCSF), today announced data on the use of mNGS for the diagnosis of infectious causes of meningitis and/or encephalitis in real-world clinical settings.

Nevro Corp. today announced that it will release its financial results for the first quarter of 2024 after the market closes on Tuesday, May 7, 2024.

Evoke Pharma, Inc. announced it will host a virtual KOL and investor webinar on Wednesday, April 24 at 12:00 p.m. ET.

Mirion (NYSE: MIR) announced today that it will release financial results for first quarter 2024 after market close on Tuesday, April 30, 2024.

Outset Medical, Inc. announced today a multi-year agreement to help accelerate home hemodialysis in the U.S.

Kuros Biosciences (SIX:KURN), a leader in next generation bone graft technologies, held its Annual General Meeting today.

The National Comprehensive Cancer Network® is announcing 2024 award recipients that include individuals and groups who have made significant and noteworthy impacts on improving cancer care and supporting NCCN’s mission to help all people with cancer to live better lives.